USL 25 (Topiragen 25 mg)
Generic Name: topiramate
Pill with imprint USL 25 is White, Round and has been identified as Topiragen 25 mg. It is supplied by Upsher-Smith Laboratories, Inc.
Topiragen is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiragen 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for USL 25
Topiragen
- Generic Name:
- topiramate
- Imprint:
- USL 25
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Upsher-Smith Laboratories, Inc
- National Drug Code (NDC):
- 00245-0711
More about Topiragen (topiramate)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Imprints, Shape & Color Data
- Drug Interactions
- 1 Review
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
Consumer resources
Other brands: Topamax, Trokendi XR, Qudexy XR, Topamax Sprinkle
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
